Ardelyx (ARDX) is emerging as a compelling, yet risky, small-cap biotech opportunity. The company has made significant ...

Lodestar Investment disclosed that its board of directors approved an increase to its authorized capital stock from 3 billion shares to 30 billion shares with the same P0.10 par value.

As we move deeper into 2025, the crypto market is buzzing with optimism. With institutional capital flowing back in, Bitcoin ...